Thu, January 25, 2024

Peter Lawson Maintained (SWTX) at Buy with Increased Target to $47 on, Jan 25th, 2024

Peter Lawson of Barclays, Maintained "SpringWorks Therapeutics, Inc." (SWTX) at Buy with Increased Target from $41 to $47 on, Jan 25th, 2024.

Peter has made no other calls on SWTX in the last 4 months.



There are 2 other peers that have a rating on SWTX. Out of the 2 peers that are also analyzing SWTX, 0 agree with Peter's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Peter


  • Corinne Jenkins of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $52 on, Wednesday, November 29th, 2023
  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $73 on, Wednesday, November 29th, 2023